@Sovereign_Beast So you seem to not understand that they do in fact have double blind studies. It is completely ethical to include an additional treatment to base treatment that is either a placebo or the experimental procedure. L https://t.co/m66WCxcKhr
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients. https://t.co/04t0gQ3j3e
Top story: A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients | Journal of Nanobiotechnology… https://t.co/ruCzNqO1iT, see more h
J Nanobiotechnology A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients: Currently, the main goal… https://t.co/xbDhmUrNxt #Resear